- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2625EUR$2,750USD£2,199GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
The Streptococci Test market is a segment of the Point-of-Care Diagnostics industry. It is focused on the development and commercialization of tests that detect the presence of Streptococcus bacteria. These tests are used to diagnose a variety of infections, including strep throat, pneumonia, and meningitis. The tests are typically performed in a doctor's office or clinic, and the results are available quickly.
The Streptococci Test market is highly competitive, with a number of companies offering products. These include Abbott, Becton Dickinson, Cepheid, DiaSorin, and Quidel. Each company offers a range of tests, with varying levels of accuracy and sensitivity. Additionally, some companies offer tests that are designed to detect multiple types of Streptococcus bacteria. Show Less Read more